Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Plummer

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
British Journal of Cancer|February 3, 2011
A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumoursR Plummer, R H Wilson, H Calvert, et al.
Developmental Neurobiology|September 14, 2011
Isolation of a novel rat neural progenitor clone that expresses Dlx family transcription factors and gives rise to functional GABAergic neurons in cultureHedong Li, Anna T Hader, Yu R Han, et al.
British Journal of Cancer|August 31, 2013
Phase I-II study of plitidepsin and dacarbazine as first-line therapy for advanced melanomaR Plummer, P Lorigan, E Brown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2014
DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanomaA Gupta, S Love, A Schuh, et al.
ESMO Open|January 5, 2023
Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugsJ K Overbeek, R Ter Heine, H M W Verheul, et al.
British Journal of Cancer|October 28, 2010
Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699R A Daniel, A L Rozanska, E A Mulligan, et al.
British Journal of Cancer|June 24, 2024
Social determinants of health inequalities in early phase clinical trials in Northern EnglandS Rae, S Shaya, E Taylor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2015
Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanomaM R Middleton, P Friedlander, O Hamid, et al.
Investigational New Drugs|November 9, 2014
A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumorsP P Peethambaram, L C Hartmann, D J Jonker, et al.
Developmental Medicine and Child Neurology|December 14, 2024
Experiences of participation in daily life of adolescents and young adults with cerebral palsy: A scoping reviewStacey L Cleary, Prue E Morgan, Margaret Wallen, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
British Journal of Cancer|February 3, 2011
A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumoursR Plummer, R H Wilson, H Calvert, et al.
Developmental Neurobiology|September 14, 2011
Isolation of a novel rat neural progenitor clone that expresses Dlx family transcription factors and gives rise to functional GABAergic neurons in cultureHedong Li, Anna T Hader, Yu R Han, et al.
British Journal of Cancer|August 31, 2013
Phase I-II study of plitidepsin and dacarbazine as first-line therapy for advanced melanomaR Plummer, P Lorigan, E Brown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2014
DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanomaA Gupta, S Love, A Schuh, et al.
ESMO Open|January 5, 2023
Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugsJ K Overbeek, R Ter Heine, H M W Verheul, et al.
British Journal of Cancer|October 28, 2010
Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699R A Daniel, A L Rozanska, E A Mulligan, et al.
British Journal of Cancer|June 24, 2024
Social determinants of health inequalities in early phase clinical trials in Northern EnglandS Rae, S Shaya, E Taylor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2015
Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanomaM R Middleton, P Friedlander, O Hamid, et al.
Investigational New Drugs|November 9, 2014
A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumorsP P Peethambaram, L C Hartmann, D J Jonker, et al.
Developmental Medicine and Child Neurology|December 14, 2024
Experiences of participation in daily life of adolescents and young adults with cerebral palsy: A scoping reviewStacey L Cleary, Prue E Morgan, Margaret Wallen, et al.
Pageof 15